CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $12.75B, above the global median of $1.18B
- PositionDebt-to-equity is 3.25×, higher than 95% of its Health Information Services peers (median 0.18×)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.75BUSDvs all stocks (USD)
Revenue (TTM)
1.43BUSDvs all stocks (USD)
Profit Margin
-17.77%vs Health Information Services peers
Beta
3.58xvs all stocks
52-Week Change
-15.11%vs all stocks
Market Capitalization
12.75BUSDvs all stocks (USD)
Enterprise Value
12.98BUSDvs all stocks (USD)
Price to Sales (TTM)
8.63xvs Health Information Services peers
Price to Book (MRQ)
27.71xvs Health Information Services peers
Enterprise to Revenue
9.07xvs Health Information Services peers
Enterprise to EBITDA
-67.15xvs Health Information Services peers
Gross Margin
64.45%vs Health Information Services peers
Profit Margin
-17.77%vs Health Information Services peers
Operating Margin
-20.11%vs Health Information Services peers
Return on Assets (TTM)
-8.55%vs Health Information Services peers
Return on Equity (TTM)
-67.44%vs Health Information Services peers
Revenue (TTM)
1.43BUSDvs all stocks (USD)
Revenue per Share (TTM)
8.05USDUpdated Aug 28, 2026Quarterly Revenue Growth
21.60%vs Health Information Services peers
Gross Profit (TTM)
916.19MUSDvs all stocks (USD)
EBITDA (TTM)
-193.36MUSDvs all stocks (USD)
Net Income (TTM)
-254.42MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
21.56%vs Health Information Services peers
Operating Cash Flow (TTM)
-237.43MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-93.49MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Aug 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Health Information Services peers
Revenue
1.27BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
473.89MUSDFY2025 · Dec 31, 2025Gross Profit
797.90MUSDFY2025 · Dec 31, 2025Operating Income
-252.87MUSDvs all stocks (USD)
Pre-tax Income
-291.10MUSDFY2025 · Dec 31, 2025Income Tax Expense
-51.68MUSDFY2025 · Dec 31, 2025Net Income
-245.03MUSDFY2025 · Dec 31, 2025EBIT
-220.83MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-106.47MUSDFY2025 · Dec 31, 2025Research & Development
319.03MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
715.43MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
12.63MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
70.27MUSDFY2025 · Dec 31, 2025EPS (Basic)
-1.41USDFY2025 · Dec 31, 2025EPS (Diluted)
-1.41USDFY2025 · Dec 31, 2025Basic Shares Outstanding
174.26MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
174.26MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-245.03MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
-226.20MUSDFY2025 · Dec 31, 2025Free Cash Flow
-247.25MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
609.45MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-245.03MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
102.32MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-52.66MUSDFY2025 · Dec 31, 2025Stock-based Compensation
124.75MUSDFY2025 · Dec 31, 2025Other Non-cash Items
25.59MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-90.40MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-7.24MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-83.53MUSDFY2025 · Dec 31, 2025Capital Expenditures
-21.05MUSDFY2025 · Dec 31, 2025Net Acquisitions
-376.67MUSDFY2025 · Dec 31, 2025Purchase of Investments
-2.74MUSDFY2025 · Dec 31, 2025Sale of Investments
8.32MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-392.14MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
1.02BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-284.73MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-3.04MUSDFY2025 · Dec 31, 2025Common Dividends Paid
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-44.10MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
884.12MUSDFY2025 · Dec 31, 2025Shares Outstanding
180.24MSharesUpdated Aug 28, 2026Float Shares
115.60MSharesUpdated Aug 28, 2026Shares Short
29.87MSharesUpdated Aug 28, 2026Short Ratio
6.10daysvs all stocks
Short % of Shares Outstanding
29.91%vs all stocks
% Held by Insiders
36.78%vs all stocks
% Held by Institutions
59.17%vs all stocks
Total Cash (MRQ)
815.99MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
4.52USDUpdated Aug 28, 2026Total Debt (MRQ)
1.44BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
3.25xvs Health Information Services peers
Current Ratio (MRQ)
3.30xvs Health Information Services peers
Book Value per Share (MRQ)
2.47USDUpdated Aug 28, 2026Total Assets
2.27BUSDvs all stocks (USD)
Total Current Assets
1.17BUSDFY2025 · Dec 31, 2025Total Liabilities
1.78BUSDFY2025 · Dec 31, 2025Total Non-current Assets
1.11BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.41BUSDFY2025 · Dec 31, 2025Total Current Liabilities
372.39MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
604.79MUSDFY2025 · Dec 31, 2025Other Short-term Investments
150.21MUSDFY2025 · Dec 31, 2025Accounts Receivable
311.17MUSDFY2025 · Dec 31, 2025Inventory
51.72MUSDFY2025 · Dec 31, 2025Accounts Payable
81.99MUSDFY2025 · Dec 31, 2025Short-term Debt
13.36MUSDFY2025 · Dec 31, 2025Deferred Revenue
108.63MUSDFY2025 · Dec 31, 2025Other Current Liabilities
8.68MUSDFY2025 · Dec 31, 2025Long-term Debt
1.31BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
56.60MUSDFY2025 · Dec 31, 2025Common Stock (Book)
18.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-2.40BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
491.33MUSDvs all stocks (USD)
Treasury Stock
6.64MUSDFY2025 · Dec 31, 202552-Week Low
40.77USDUpdated Aug 28, 202652-Week High
104.32USDUpdated Aug 28, 202652-Week Change
-15.11%vs all stocks
Beta
3.58xvs all stocks
50-Day MA
53.73USDUpdated Aug 28, 2026200-Day MA
56.60USDUpdated Aug 28, 2026Avg 10-Day Volume
9.63MSharesUpdated Aug 28, 2026Avg 30-Day Volume
6.73MSharesUpdated Aug 28, 2026Diluted EPS (TTM)
-1.44USDUpdated Aug 28, 2026Other Income / Expense
19.41MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 3.25×, higher than 95% of its Health Information Services peers (median 0.18×)Significant
Debt-to-equity: 3.25Industry median: 0.18Industry P95: 2.57Peers compared: 53.00
Price-to-book is 27.71×, higher than 95% of its Health Information Services peers (median 3.28×)Significant
Price-to-book: 27.71Industry median: 3.28Industry P95: 24.73Peers compared: 53.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.64Profit Margin: -0.18
Significant cash reserves alongside high leverageNotable
Cash (USD): 815,990,976Total Debt (USD): 1,444,167,936Debt-to-Equity: 3.25
Financial Health
Altman Z-Score 3.47: safe zoneNotable
Altman Z-Score: 3.47
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $12.75B, above the global median of $1.18BNotable
Market cap (USD): 12,754,932,901Global Median: 1,179,398,897.704
Revenue is $1.43B, above the global median of $534.05MNotable
Revenue (USD): 1,432,018,944Global Median: 534,052,387.958
Companies that share the same coordination system — how they create, deliver, or capture value.
Dynatrace, Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
InterDigital, Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InRuleProduction
Clearwater Analytics Holdings Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceFlow
Beijing Compass Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceFlow
Qualys, Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InRuleProduction
NIQ Global Intelligence PLC
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceFlow
HeartFlow, Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
Geovis Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Kinaxis Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowInterface
Shenzhen Intellifusion Technologies Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Power Solutions International, Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Kangwon Energy Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated